Annia Cavazos
Internal Medicine · Lubbock, TXNPI 1356964209
Payments from drug & device makers
Across 81 payments — averaging $42.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$448
- Sanofi$436
- Galderma Laboratories, L.p.$360
- Amgen$287
- Johnson & Johnson$253
- Sun Pharmaceutical Industries Inc.$167
- plus $2K from 14 others
What the payments were for
- Food & beverage$3,26094%
- Education$1996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $448 |
| Sanofi | 4 | $436 |
| Galderma Laboratories, L.p. | 11 | $360 |
| Amgen | 11 | $287 |
| Johnson & Johnson | 12 | $253 |
| Sun Pharmaceutical Industries Inc. | 5 | $167 |
| Arcutis Biotherapeutics, Inc. | 1 | $165 |
| UCB, Inc. | 3 | $163 |
| Novartis | 6 | $160 |
| LEO Pharma Inc. | 1 | $148 |
| Inari Medical, Inc. | 1 | $146 |
| Revance Therapeutics, Inc. | 1 | $125 |
| Boehringer Ingelheim | 1 | $124 |
| Kyowa Kirin, Inc. | 1 | $119 |
| Lilly USA, LLC | 1 | $105 |
| Pfizer | 2 | $79 |
| AbbVie | 3 | $55 |
| Chiesi USA, Inc. | 2 | $47 |
| Organon | 2 | $40 |
| Genentech USA, Inc. | 2 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,459 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 19 | $245,006 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 35 | $2,731 |
| Ketoconazole | 68 | $1,156 |
| Clobetasol Propionate | 19 | $1,102 |
| Fluorouracil | 13 | $820 |
| Halobetasol Propionate | 15 | $782 |
| Hydroxychloroquine Sulfate | 26 | $463 |
| Fluocinonide | 15 | $341 |
| Triamcinolone Acetonide | 21 | $250 |
| Hydrocortisone | 22 | $192 |
| Doxycycline Monohydrate | 11 | $172 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lubbock
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.